Previous studies have shown that SRPX2 and SPARC were overexpressed in gastric cancer tissues [28-30], while TLN2 was upregulated in breast carcinomas tissues [31]; however, no studies investigating the expression of TLN2, SRPX2, and SPARC in peripheral blood have been reported. Here, SRPX2 is linked to breast carcinoma.